Rex requires investor leap of faith
Latest clinical trial results for robotic leg device-maker Rex Bionics' (RXB:AIM) have done little to ease major sales concerns. Tests are aimed at showing that these robotic devices can provide meaningful support for spinal injury...
27 November 2015
